Accurate Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $500K | Sell |
1,044
-385
| -27% | -$185K | 0.08% | 266 |
|
2025
Q1 | $692K | Buy |
1,429
+512
| +56% | +$248K | 0.13% | 159 |
|
2024
Q4 | $375K | Buy |
917
+56
| +7% | +$22.9K | 0.07% | 247 |
|
2024
Q3 | $417K | Buy |
861
+335
| +64% | +$162K | 0.08% | 233 |
|
2024
Q2 | $258K | Buy |
+526
| New | +$258K | 0.06% | 260 |
|
2024
Q1 | – | Sell |
-555
| Closed | -$239K | – | 307 |
|
2023
Q4 | $239K | Buy |
+555
| New | +$239K | 0.07% | 240 |
|
2023
Q1 | – | Sell |
-421
| Closed | -$122K | – | 1436 |
|
2022
Q4 | $122K | Buy |
+421
| New | +$122K | 0.04% | 277 |
|
2022
Q1 | – | Sell |
-1,396
| Closed | -$262K | – | 194 |
|
2021
Q4 | $262K | Buy |
1,396
+50
| +4% | +$9.38K | 0.21% | 116 |
|
2021
Q3 | $244K | Buy |
1,346
+216
| +19% | +$39.2K | 0.21% | 117 |
|
2021
Q2 | $228K | Buy |
+1,130
| New | +$228K | 0.2% | 120 |
|